N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE
|
|
N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE Eigenschaften
- Dichte
- 1.41±0.1 g/cm3(Predicted)
- pka
- 14.45±0.70(Predicted)
Sicherheit
N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE Chemische Eigenschaften,Einsatz,Produktion Methoden
N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 3)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Matrix Scientific | -- |
sales@matrixscientific.com | United States | 6632 | 80 |
Key Organics Limited/Bionet Research | -- |
enquiries@keyorganics.ltd.uk | United Kingdom | 6663 | 50 |
Ryan Scientific, Inc. | -- |
ryan.reichlyn@ryansci.com | United States | 6439 | 60 |
- N-(4-([3-ETHYL-4-OXO-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-5-YLIDEN]METHYL)PHENYL)ACETAMIDE
- N-(4-{[3-Ethyl-4-oxo-2-(4H-1,2,4-triazol-4-ylimino)-1,3-thiazolan-5-yliden]methyl}phenyl)aceta
- N-[4-({3-ethyl-4-oxo-2-[(4H-1,2,4-triazol-4-yl)imino]-1,3-thiazolidin-5-ylidene}methyl)phenyl]acetamide
- N-(4-((2-((4H-1,2,4-triazol-4-yl)imino)-3-ethyl-4-oxothiazolidin-5-ylidene)methyl)phenyl)acetamide
- Acetamide, N-[4-[[3-ethyl-4-oxo-2-(4H-1,2,4-triazol-4-ylimino)-5-thiazolidinylidene]methyl]phenyl]-
- 478078-12-5